Coriolis Ventures

What Coriolis Ventures does

Coriolis Ventures is a New York-based early-stage venture capital firm founded by Joshua Abram and Alan Murray, partners for over two decades. The firm identifies and backs category-creating companies across diverse sectors — digital advertising (Dstillery, Integral Ad Science, AppNexus), hospitality (NeueHouse, Alice), and life sciences and fertility technology (TMRW Life Sciences, AutoIVF, Conceivable Life Sciences). Coriolis does not develop proprietary technology products; its offering is earliest-stage capital combined with deep operating involvement, with the founders typically taking Co-CEO roles at portfolio companies and leading operations through critical growth phases.

The firm's revenue model is traditional venture economics: equity stakes in early-stage companies generating returns via exits. Notable liquidity events include AppNexus acquired by AT&T for $1.6 billion in 2018, Alice acquired by Expedia, Beboe acquired by Green Thumb for $125 million in 2019, and Integral Ad Science's NASDAQ listing. As of December 2021, companies co-founded by the founders held a combined market value exceeding $5 billion. Day-to-day revenue for Coriolis itself — a 1–10 employee firm headquartered at 160 Mercer Street, 3rd Floor, New York — is driven primarily by management fees on its fund(s) plus lumpy carried interest realizations; the firm does not publicly disclose AUM, fund size, or annual revenue.

Distribution and origination are founder-led. Deal flow originates from the founders' personal networks and founder-to-founder referrals, supported by limited marketing surfaces (a website, a newsletter subscription, LinkedIn profiles for both principals, and earned media coverage across tier-1 outlets including Bloomberg, CNN, the Wall Street Journal, the Financial Times, Fortune, the New York Times, and Architectural Digest). Since 2018, the firm has concentrated thesis-driven capital in fertility and IVF-lab automation, founding three operating companies in that vertical (TMRW 2018, AutoIVF 2021, Conceivable 2022) and stacking complementary offerings across the IVF workflow.

Name

Coriolis Ventures

Legal name

Coriolis Ventures

Website

http://coriolisventures.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Short description

Coriolis Ventures is a New York-based early-stage venture capital firm, founded by Joshua Abram and Alan Murray, that co-creates and backs category-defining startups across advertising, hospitality, life sciences, and fertility, frequently taking operating Co-CEO roles at portfolio companies.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

All Other Financial Investment Activities (52399), Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

akta.pro secondary industries

Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA), Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Early-stage venture capital
• Startup incubation
• Seed funding
• Operational leadership
• Fertility technology investing

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Venture Capital Returns: Coriolis Ventures generates returns through equity stakes in early-stage companies. The firm benefits from exits through acquisitions (e.g., AT&T acquiring AppNexus for $1.6B, Expedia acquiring Alice, Green Thumb acquiring Beboe for $125M) and public market listings (Integral Ad Science on NASDAQ). Returns flow through carried interest to the firm and its partners.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Coriolis Ventures is an early-stage venture capital and incubation firm that provides the earliest capital to startups and co-founds companies across technology, hospitality, and life sciences. The founders serve as Co-CEOs of portfolio companies, offering operational leadership alongside financial investment, with a notable focus on disruptive fertility technologies since 2018.

Product overview

Coriolis Ventures is a venture capital firm, not a product company. It does not offer its own product or service offering. The company invests in and co-founds technology companies across sectors including digital advertising, life sciences/IVF technology, hospitality, and social networking.

Differentiator

Problem solved

Functional benefit

Products and services

• Early-Stage Venture Capital Funding
• Founder Co-CEO Operational Partnership
• Fertility Technology Investment Program

Quantifiable outcome

• Over $5 billion in combined market value of co-founded companies as of December 2021
• +1 more outcomes

Named customers8 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Betaworks: NYC-based early-stage incubator/VC that builds and invests in category-defining companies with active founder involvement. Operates a similar capital-plus-operator model to Coriolis Ventures at comparable check sizes.
• Lux Capital: Sector-focused early-stage VC known for deep domain expertise in frontier technologies including life sciences. Comparable to Coriolis Ventures given its vertical specialization and willingness to lead early.
• Bloomberg Beta: Early-stage venture fund investing with a thesis-driven, sector-spanning approach. Comparable as a small, partner-led firm focused on early stages across multiple verticals.
• Lerer Hippeau: NYC early-stage venture fund investing across consumer, media, and enterprise with operator support. Comparable as a small, founder-led early-stage firm in the same geography.
• Collaborative Fund: Early-stage venture firm focused on category-creating companies across consumer, tech, and health. Comparable given similar stage focus and thematic specialization including health/life sciences.
• Story Ventures: NYC-based operator-led early-stage VC. Comparable as a small, founder-led fund providing operational support and 'founder-underwriting' style capital to seed-stage companies.

Broad incumbents

• Techstars: Global accelerator/early-stage investor with an active NYC presence. Comparable as an early-stage capital provider that takes active operational roles in portfolio companies, though at much larger scale.
• Founders Fund: Prominent early-stage VC backing founder-led, category-defining companies. Comparable given its emphasis on early entry into transformative companies, though at significantly greater scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/in/joshuaabram

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments15 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Coriolis Ventures